Adia Med, Inc.
ADIA · OTCMCIK 1160420fmd_1MWJ58SNY9V427PBY18QD73DM4Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2024 to Jun 30, 2026, 6 periods
| Line item | FY2024 | FY2025 |
|---|---|---|
| Total revenues | 0 | 1 |
| Cost of revenue | 0 | 1 |
| Gross profit | 0 | 0 |
| Research and development | 0 | 0 |
| Compensation and benefits | 0 | 0 |
| Total operating expenses | 0 | 1 |
| Operating income | (0) | (0) |
| Interest expense | 0 | 0 |
| Other non-operating income (expense) | (0) | (0) |
| Income before taxes | (0) | (0) |
| Income tax expense | 0 | 0 |
| Net income from continuing operations | (0) | (0) |
| Net income | (0) | (0) |